Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06794476 · ClinicalTrials.gov registry record · NA

Milieu Teaching-AV (MT-AV Pilot)

A NA study of Autism Spectrum Disorder and Autism Sibling, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT06794476: Recruiting NA study of Autism Spectrum Disorder and Autism Sibling, sponsored by Vanderbilt University Medical Center.

NCT06794476 is a NA study of Autism Spectrum Disorder and Autism Sibling that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 8 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06794476, a NA study of Autism Spectrum Disorder and Autism Sibling, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

This project will look at whether a novel approach to language intervention that encourages looking to audiovisual speech cues for infants with autistic older siblings (Baby Sibs), who are highly likely be diagnosed with autism or developmental language disorder (DLD). This study will specifically look at (a) whether caregivers find this approach to be easy to implement in their homes, (b) whether they find this approach to be acceptable, and (c) whether caregivers use the taught strategies in interactions with their infants.

Interventions

  • BEHAVIORAL Milieu Teaching-AV

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2025-01-30
Est. Completion 2025-12
Phase NA

What NCT06794476 shows while recruiting

NCT06794476 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (94% lower).

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Milieu Teaching-AV is the first listed.

NCT06794476 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT06794476 about?

NCT06794476 is a clinical study titled "Milieu Teaching-AV (MT-AV Pilot)". This project will look at whether a novel approach to language intervention that encourages looking to audiovisual speech cues for infants with autistic older siblings (Baby Sibs), who are highly likely be diagnosed with autism or developmental language disorder (DLD). This study will specifically l...

What is the current status of trial NCT06794476?

This trial is currently recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2025-01-30. Estimated completion is 2025-12.

What conditions does trial NCT06794476 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism Sibling.

What interventions are being tested in trial NCT06794476?

The interventions under investigation include: Milieu Teaching-AV (BEHAVIORAL).

Who is sponsoring clinical trial NCT06794476?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06794476 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06794476's enrollment target sits among peer trials

8 221st of 224 higher than 2 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06794476, the US trial registry maintained by the National Library of Medicine. NCT06794476 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.